PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 104 results · Rare Diseases  · Clear
🔒 Subscribers only
AUTH/3003/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Clinuvel UK
A complaint was brought by the PMCPA Director against Clinuvel UK.The subject matter related to clinical trial disclosure for Scenesse.Complaint received: 20 December 2017.
Clauses: NONE
🔒 Subscribers only
AUTH/3002/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Octapharma
The PMCPA Director raised a case against Octapharma concerning clinical trial disclosure relating to Nuwiq.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
🔒 Subscribers only
AUTH/2967/8/17
Off-label Promotion Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Consultant v Shire
A consultant complained about Shire.The complaint alleged omission of prescribing information and other obligatory information.Case reference: AUTH/2967/8/17.Complaint received: 08 August 2017.Appl…
Clauses: NONE
🔒 Subscribers only
AUTH/2979/9/17
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
PharmaMar
A case was brought by an anonymous, non-contactable complainant against PharmaMar.The case reference is AUTH/2979/9/17.No further factual background was provided in the supplied case text.
🔒 Subscribers only
AUTH/2939/2/17
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK & Astellas Europe
Astellas UK and Astellas Europe made a joint voluntary admission that prescribing information (PI) used in UK promotion was incomplete for multiple medicines. The issue was discovered during routin…
Clauses: NONE
🔒 Subscribers only
AUTH/2886/11/16
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained about a Vifor Pharma UK promotional leavepiece for Ferinject (iron carboxymaltose) titled “Their world awaits” (ref UK/FER/16/0116).The front page included a red box sta…
Clauses: NONE
🔒 Subscribers only
AUTH/2885/11/16
Off-label Promotion Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Gedeon Richter
An anonymous (non-contactable) complainant, describing themselves as a senior obstetrics & gynaecology doctor, complained about an Esmya (ulipristal acetate) patient support leaflet (ref UK/ESM…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2819/2/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
A general practitioner complained that Jinarc (tolvaptan) patient support materials portrayed the medicine as a treatment for ADPKD, amounting to advertising to the public and risking raised patien…
Clauses: NONE
🔒 Subscribers only
AUTH/2827/3/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Novartis
An anonymous hepatologist complained about a Novartis tweet relating to liver disease.The complaint was received on 10 March 2016.The case was completed on 13 April 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2891/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas
An ex-employee made a complaint about Astellas.The case topic is listed as “Certification and review of materials”.The PMCPA considered the matter under the ABPI Code process.
Clauses: NONE
🔒 Subscribers only
AUTH/2894/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Mitsubishi Tanabe
A complaint was brought by the Director against Mitsubishi Tanabe.The subject matter related to clinical trial disclosure for BindRen.The case was completed on the same date it was received.
Clauses: NONE
🔒 Subscribers only
AUTH/2848/5/16
Off-label Promotion Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring
Ferring voluntarily admitted that an area sales manager encouraged representatives to facilitate a local hospital sending a letter to GP practices promoting DesmoMelt (sublingual desmopressin) inst…
Clauses: NONE
🔒 Subscribers only
AUTH/2845/5/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Swedish Orphan Biovitrum
CSL Behring complained about a “Sobi Charity Ball” and a public advertisement/invitation posted on Sobi’s and a charity’s website.The advert stated a £65 ticket price including arrival dri…
Clauses: NONE
🔒 Subscribers only
AUTH/2844/5/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Amdipharm Mercury
Amdipharm Mercury Company (AMCo) voluntarily admitted that a representative sent an unapproved promotional email about Lutrate (leuprorelin) to a prescribing advisor.The email was discovered during…
Clauses: NONE
🔒 Subscribers only
AUTH/2924/12/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Lincoln Medical website
An anonymous, non-contactable pharmacist complained about statements on Lincoln Medical’s website.The ‘About us’ page (and similar wording on a ‘Products’ page) named prescription only me…
Clauses: NONE
🔒 Subscribers only
AUTH/2878/10/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Meda
A member of the public complained about a Facebook post by a mother of a child with life-threatening allergies.The post showed a photo of two EpiPens and text supporting the “#carrytwocampaign”…
Clauses: NONE
🔒 Subscribers only
AUTH/2874/9/16
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield
A health professional complained about a one-page Feraccru (ferric maltol) journal advertisement by Shield Therapeutics UK (Gastrointestinal Nursing, September 2016; ref UK/FER/2016/004f).The ad st…
Clauses: NONE
🔒 Subscribers only
AUTH/2805/12/15
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Guerbet
Bayer complained that Guerbet (and others) offered radiological contrast injection equipment on long-term loan or as a gift to customers who agreed to purchase the company’s contrast agent.Bayer …
Clauses: NONE
🔒 Subscribers only
AUTH/2809/12/15
HCP Hospitality & Meetings Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Amicus Therapeutics
Sanofi Genzyme complained about a 30-minute Amicus Therapeutics presentation at a patient organisation international network meeting in the UK (November 2015) attended by patient organisation repre…
Clauses: NONE
🔒 Subscribers only
AUTH/2769/5/15
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Takeda
PMCPA Director considered a matter relating to clinical trial disclosure for Rienso involving Takeda.The case was assessed under the ABPI Code applicable in 2015.
Clauses: NONE
🔒 Subscribers only
AUTH/2721/7/14
HCP Hospitality & Meetings Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire v Genzyme
Shire complained about Genzyme materials (a pre-circulated narrative and slide deck) used for a meeting of the Lysosomal Storage Disorders Expert Advisory Group (LSDEAG) on 26 February 2014. The …
Clauses: NONE
🔒 Subscribers only
AUTH/2694/1/14
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Anonymous v Pharmacosmos (AUTH/2694/1/14)
An anonymous, contactable complainant challenged Monofer (iron (III) isomaltoside 1000) content across two linked sites: the UK corporate site (pharmacosmos.co.uk) and the product site (monofer.com…
Clauses: NONE
🔒 Subscribers only
AUTH/2688/1/14
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Auxilium
A member of the public made a complaint concerning clinical trial disclosure relating to Xiapex.The PMCPA considered whether the matter fell within the scope of the ABPI Code of Practice.
Clauses: NONE
🔒 Subscribers only
AUTH/2635/8/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Anonymous v Norgine
An anonymous complainant from the academic anaesthetic community challenged a Norgine website press release about Dantrium (dantrolene) for malignant hyperthermia (MH).The press release headline re…
Clauses: NONE
← Prev 1 2 3 4 5 Next → Page 3 of 5 — 104 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews